Form 8-K - Current report:
SEC Accession No. 0001193125-25-183075
Filing Date
2025-08-19
Accepted
2025-08-19 08:14:45
Documents
14
Period of Report
2025-08-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d30469d8k.htm   iXBRL 8-K 28304
2 EX-99.1 d30469dex991.htm EX-99.1 16981
6 GRAPHIC g30469g0816032936064.jpg GRAPHIC 6480
  Complete submission text file 0001193125-25-183075.txt   175406

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA evh-20250818.xsd EX-101.SCH 2863
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE evh-20250818_lab.xml EX-101.LAB 17992
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evh-20250818_pre.xml EX-101.PRE 11270
16 EXTRACTED XBRL INSTANCE DOCUMENT d30469d8k_htm.xml XML 3670
Mailing Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209
Business Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 251229703
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)